2013 第四届国际神经科技大会会议日程
Theme: A New Era in Cancer Research and Therapy
Time: May 23-25, 2013
Venue: Hilton Xi'an, China
Opening Ceremony & Keynote Forum
Time: 09:40-12:10, May 23, 2013 (Thursday) Place: Yan Huang Hall, 2nd Floor, Hilton Xi'an
Moderator
Dr. Xiaoyan Jiang, Senior Scientist, Associate Professor, BC Cancer Research Centre, University of
British Columbia, Canada
09:40-10:10
Title: Personalized Cancer Medicine: Conceptual, Organizational and Financial Challenges
Dr. Alexander Maximiliaan Eggermont, Professor and Director, Institute Gustave Roussy, France
10:10-10:40
Title: Changing Landscape in Clinical Oncology Phase 1: Can We More Efficiently Translate Our Growing
Biological Understanding of Cancer into Relevant Novel Treatments?
Dr. Bruno Osterwalder, Senior Vice President, Senior Strategic Advisor Oncology, Merck Serono
Darmstadt, Switzerland
10:40-11:10
Title: New Drugs Developed in China for NSCLC in Recent Years
Dr. Yan Sun, Member of Chinese Academy of Engineering; Director, National GCP Center for Anticancer
Agents, Cancer Hospital/Institute, CAMS &PUMC, China
11:10-11:40
Title: Cancer Targeting Gene-Viro-Therapy (CTGVT)
Dr. Xin-Yuan Liu, Member of Chinese Academy of Sciences, Institute of Biochemistry and Cell Biology;
Professor, College of Life Science, Zhejiang Sci-Tech University, China
11:40-12:10
Title: Viral Cancer Vaccines and Tumor Associated Antigens (TAA) in Immunotherapy, Preventive and
Curative
Dr. Giulio Tarro, President, Foundation De Beaumont Bonelli, Sbarro Health Research Organization,
Adjunct Professor, Temple University, USA
Chapter 1: Cancer Related Policy and Public Health
Stream 101: Cancer Related Policy and Public Health
Time: 13:30-16:15, May 23, 2013 (Thursday) Place: Xian Yang Hall, 2nd Floor, Hilton Xi'an
Chair
Co-Chair
Dr. Bo Hang, Staff Scientist, Life Sciences Division, Lawrence Berkeley National Laboratory, USA
Dr. Jennifer E Gallagher, Reader in Oral Health Services Research; Honorary Consultant in Dental
Public Health, King's College London Dental Institute At Guy's, St Thomas's and King's College Hospitals,
UK
13:30-13:55
Title: A Targeted Approach to Raising Awareness of the Early Signs of Cancer Amongst, African, Asian,
African Caribbean, Irish and Chinese Communities Living in England
Dr. Paula Lloyd Knight, Associate Director, National Cancer Action Team, UK
13:55-14:20
Title: Thirdhand Smoke (THS) Causes DNA Damage in Human Cells
Dr. Bo Hang, Staff Scientist, Life Sciences Division, Lawrence Berkeley National Laboratory, USA
14:20-14:45
Title: Maternal Passive Smoking during Pregnancy and Neonatal Health
Dr. Artur Wdowiak, Head of Laboratory of Diagnostic Procedures, Medical University in Lublin, Poland
14:45-15:10
Title: Cancer: A Time Bomb for Indonesia
Dr. Hasbullah Thabrany, Chairman, Center for Health Economics and Policy Studies, Universitas
Indonesia, Indonesia
15:10-15:25
Coffee Break
15:25-15:50
Title: The Public Health Aspects of Tobacco Control Revisited
Dr. Jennifer E Gallagher, Reader in Oral Health Services Research; Honorary Consultant in Dental
Public Health, King's College London Dental InstituteAt Guy's, St Thomas's and King's College Hospitals,
UK
15:50-16:15
Title: The Impact of Pesticide Exposure on Breast Cancer Incidence: Evidence from Costa Rica
Dr. Carolina Santamaria-Ulloa, Professor, Universidad de Costa Rica, Costa Rica
Chapter 2: Cancer Epidemiology and Prevention
Stream 201: Cancer Genetics, Epidemiology, Biostatistics and Prevention
Time: 13:30-17:05, May 23, 2013 (Thursday) Place: Yan An Hall, 2nd Floor, Hilton Xi'an
Chair
13:30-13:55
Dr. Karan P. Singh, Professor, Department of Medicine, University of Alabama at Birmingham, USA
Title: An Innovative Model for Predicting Outcome in Cancer Patients
Dr. Karan P. Singh, Professor, Department of Medicine, University of Alabama at Birmingham, USA
13:55-14:20
Title: Association of CD44 Polymorphisms with Early Onset of Breast Cancer
Dr. Juhua Zhou, Professor, Institute for Tumor Immunology, Ludong University School of Life Sciences,
China
14:20-14:45
Title: Esophageal Adenocarcinomas: Do Phytoestrogens Play a Role?
Dr. Yunxia Lu, Associate Professor, Karolinska Institute, Sweden
14:45-15:10
Title: An Aberrant Hypermethylated Gene in NPC
Dr. Hsin-Pai Li, Assistant Professor, Chang Gung University, Taiwan
15:10-15:25
Coffee Break
15:25-15:50
Title: Cutaneous Adult T-Cell Leukemia/Lymphoma (ATLL)
Dr. Masahiro Amano, Associate Professor, Department of Dermatology, University of Miyazaki, Japan
15:50-16:15
Title: Evolution of a Transmissible Cancer: The Genetics and Epigenetics of the Tasmanian Devil Facial
Tumour Disease
Dr. Beata Ujvari, Postdoctoral Fellow, Faculty of Veterinary Science, University of Sydney, Australia
16:15-16:40
Title: Increased Incidence of Merkel Cell Carcinoma among Younger Statin Users
Dr. Helka Tuulia Sahi, Researcher, Department of Pathology, Department of Plastic and Reconstructive
Surgery, Helsinki University, Finland
16:40-17:05
Title: A Human Tumor Genome Project: From Sequence to Structure, Function and Possibly Drug Targets
Dr. Jun Chen, Director, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, China
Stream 202: Cancer Screening, Monitoring, and Counseling for High-Risk Populations
Time:13:30-15:10, May 24, 2013 (Friday) Place: Yan An Hall, 2nd Floor, Hilton Xi'an
Chair
Co-Chair
Dr. Gian Dorta, Professor, CHUV, University Hospital Lausanne, Switzerland
Dr. Eleanor O’Sullivan, Chair of Mouth Head and Neck Cancer Awareness Ireland, University College
Cork, Ireland
13:30-13:55
Title: The Use of a Blood Based Pre-cancer, Non-pathological Risk Factor to Improve Compliance, Early
Stage Detection Yield and Reduce Mortality and Health Costs of Colorectal Cancer
Dr. Dayan Goodenowe, President and CEO, Phenomenome Discoveries Inc., Canada
13:55-14:20
Title: A New Blood-based Test for Colorectal Cancer Screening
Dr. Gian Dorta, Professor, CHUV, University Hospital Lausanne, Switzerland
14:20-14:45
Title: Risk Adapted Screening in Bladder Cancer with the Internet Based Assessment Tool RiskCheck
Bladder Cancer
Dr. Gerson Ludecke, Senior Staff Urologist and Medical-Oncologist, UKGM Giessen, University Clinic,
Germany
14:45-15:10
Title: A Novel Cancer Screening Indices Based on Plasma Free Amino Acid Profiles
Dr. Minoru Yamakado, Special Adviser, Center for Multiphasic Health Testing and Services, Mitsui
Memorial Hospital, Japan
15:10-15:25
Coffee Break
Stream 203: Tobacco and Cancers
Time: 15:25-17:30, May 24, 2013 (Friday) Place: Yan An Hall, 2nd Floor, Hilton Xi'an
Chair
Dr. Yuan-Soon Ho, Professor, Chairman, Translational Cancer Research Center, Graduate Institute of
Biomedical Technology, Taipei Medical University, Taiwan
Co-Chair
15:25-15:50
Dr. Patrizia Russo, Senior Researcher, IRCCS "San RaffaelePisana", Italy
Title: Tea Polyphenols against Smoking-induced Worse-effects in Human Diseases through Inhibition of
9-nicotinic Receptor Expression
Dr. Yuan-Soon Ho, Professor, Chairman, Translational Cancer Research Center, Graduate Institute of
Biomedical Technology, Taipei Medical University, Taiwan
15:50-16:15
Title: Nicotine Promotes Human Bronchial Epithelial Cells “HBEpC” Transformation Induced by
Benzo[a]pyrene-7,8-diol-9,10-epoxide through a7-nicotinic Receptor Mediated Pathways
Dr. Patrizia Russo, Senior Researcher, IRCCS "San RaffaelePisana", Italy
16:15-16:40
Title: Perspectives of Breast Cancer Etiology
Dr. Hong-Hong Zhu, Assistant Professor, Western kentucky University, USA
16:40-17:05
Title: The Analysis of the Human Whole Saliva Proteome of Heavy Smokers for Potential Biomarkers for
Tobacco Related Diseases
Dr. Zubaidah Haji Abdul Rahim, Professor, Department of Oral Biology, Faculty of Dentistry, University
of Malaya, Malaysia
17:05-17:30
Title: Tobacco and Lung Cancer Incidence among Males
Dr. Padmavath Amma Jayalekshmi, Assistant Professor, Regional Cancer Center, India
Chapter 3: Etiology of Cancer
Stream 301: Cancer-related DNA Damage, Repair and Cell Cycle
Time: 13:30-17:05, May 23, 2013 (Thursday) Place: Shen Mu Hall, 2nd Floor, Hilton Xi'an
Chair
Co-Chair
Dr. Xiao Xu, CEO, ACEA Biosciences Inc., USA
Dr. Eileen McGowan, Senior Research Fellow, Translational Cancer Research, University of Technology
Sydney, Australia
13:30-13:55
Title: New Approaches in Mechanistic Study of Cancer Metastasis
Dr. Xiao Xu, CEO, ACEA Biosciences Inc., USA
13:55-14:20
Title: Cancers and the Concept of Cell Senescence
Dr. Alvaro Macieira-Coelho, Director of Research, National Institute of Health and Medical Research
(INSERM), France
14:20-14:45
Title: PET-guided High-dose IMRT with Self-respiratory Gating in the Treatment of Non-small Cell Lung
Cancer
Dr. Jidong Lian, Staff Radiation Oncologist, Credit Valley Hospital, Trillium Health Partners, Canada
14:45-15:10
Title: Evaluation of Cell Cycle Arrest in Estrogen Responsive Breast Cancer Cells
Dr. Eileen McGowan, Senior Research Fellow, Translational Cancer Research, University of Technology
Sydney, Australia
15:10-15:25
Coffee Break
15:25-15:50
Title: Coordinated Utilization of Glucose and Glutamine Is Critical for Cell Proliferation
Dr. Nianli Sang, Associate Professor, Drexel University, USA
15:50-16:15
Title: Dicer, DNA Damage and Tumorigenesis
Dr. Kaifu Tang, Professor, Chongqing Medical University, China
16:15-16:40
Title: Combretastatin Analogues and Their Metal Complexes: The Powerful Combination of DNA Targeting
with Antimitotic Activity
Dr. Bernhard Biersack, Visiting Professor of Chemistry, AbedaInamdar Senior College, University of
Pune, India
16:40-17:05
Title: The Other Faces of the PIM-2 Oncogene - Cell Cycle Arrest, Activation of Apoptosis, and Involvement
in the DNA Damage Response
Dr. Jeremy Don, The Mina &Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Israel
Stream 302: Oncogenes, Tumor Suppressors and Carcinogens
Time: 13:30-17:30, May 24, 2013 (Friday) Place: Shen Mu Hall, 2nd Floor, Hilton Xi'an
Chair
Dr. Yanping Zhang, Professor, Department of Radiation Oncology and Lineberger Comprehensive
Cancer Center, School of Medicine, University of North Carolina at Chapel Hill, USA
Co-Chair
13:30-13:55
Dr. Gunnar Westin, Professor, Department of Surgical Sciences, Uppsala University, Sweden
Title: The RP-Mdm2-p53 Pathway Links Nutrient Stress to Liver Lipid Metabolism, Obesity, and Cancer
Dr. Yanping Zhang, Professor, Department of Radiation Oncology and Lineberger Comprehensive
Cancer Center, School of Medicine, University of North Carolina at Chapel Hill, USA
13:55-14:20
Title: Hypermethylation of Tumor Suppressor Genes in Breast Cancer
Dr. Yinhua Yu, Professor, Obstetrics and Gynecology Hospital of Fudan University, China
14:20-14:45
Title: Hypermethylated in Cancer 1 (HIC1), a Tumor Suppressor Gene Epigenetically Deregulated in
Hyperparathyroid Tumors by Histone H3 Lysine Modification
Dr. Gunnar Westin, Professor, Department of Surgical Sciences, Uppsala University, Sweden
14:45-15:10
Title: The Regulation of p53 Isoforms
Dr. Geng Liu, Associate Professor, Soochow University, China
15:10-15:25
Coffee Break
15:25-15:50
Title: Two Single Nucleotide Polymorphisms in the Von Hippel-lindau (Vhl) Tumor Suppressor Gene in
Taiwanese Population with or without Renal Cell Carcinoma
Dr. Yen-Chein Lai, Assistant Professor, Chung Shan Medical University, Taiwan
15:50-16:15
Title: Tumor Suppressive Activity of Smad3 through Regulation of Mir-200 Members in Gastric Cancer
Dr. Suntaek Hong, Associate Professor, Lee Gil Ya Cancer and Diabetes Institute, Gachon University,
South Korea
16:15-16:40
Title: FBXW7 Institutes the Very Last Failsafe Program Against Tumor Progression Right Prior to the Early
Stages of Metastasis
Dr. Ningning Li, Research Associate, University College London, UK
16:40-17:05
Title: Distinct Regulation of Tumor Suppressor Genes by the Transcription Factor E2F in Response to
Growth Stimulation and Oncogenic Changes
Dr. Kiyoshi Ohtani, Professor, Department of Bioscience, KwanseiGakuin University, Japan
17:05-17:30
Title: Role of CD44 in Antigen Presentation and Its Implication in Anti-tumor Immune Response
Dr. Juhua Zhou, Distinguished Professor and (Taishan Scholar)Director, Institute for Tumor Immunology,
Ludong University School of Life Sciences, China
Stream 303: Tumor Angiogenesis
Time: 08:30-09:45, May 25, 2013 (Saturday) Place: Shen Mu Hall, 2nd Floor, Hilton Xi'an
Chair
Dr. Emanuela Masini, Professor, Department of NEUROFARBA, Section of Pharmacology, University of
Florence, School of Medicine, Italy
08:30-08:55
Title: Selective Inhibition of Carbonic Anhydrase Ix: Target Enzyme for Diagnosis and Therapy of Renal
Carcinoma
Dr. Emanuela Masini, Professor, Department of NEUROFARBA, Section of Pharmacology, University of
Florence, School of Medicine, Italy
08:55-09:20
Title: The Anti-hepatocarcinogenic Effect of Mushroom Extract is Mediated by the Inhibition of
VEGF-induced PI3K/AKT Signaling Pathway
Dr. Peter Cheung, Professor, School of Life Sciences, The Chinese University of Hong Kong, China
09:20-09:45
Title: A T-cadherin: Role in Melanoma Growth, Angiogenesis and Stromal Cell Recruitment
Dr. Kseniya Rubina, Faculty of Basic Medicine, M.V. Lomonosov Moscow State University, Russia
Stream 304: Cancer/Tumor Metastasis, Adhesion, Migration, and Invasion
Time: 13:30-16:15, May 25, 2013 (Saturday) Place: Shen Mu Hall, 2nd Floor, Hilton Xi'an
Chair
Co-Chair
Dr. Tao Liu, Group Leader, Children's Cancer Institute Australia for Medical Research, Australia
Dr. Ronald Y Chin, Consultant Otolaryngologist, Head and Neck Surgeon, Lecturer, Nepean Hospital,
The University of Sydney, Australia
13:30-13:55
Title: Multiple Steps of HLA-G in Ovarian Carcinoma Metastasis: alter NK Cytotoxicity and Induce
MMP-15 Expression
Dr. Wei Hua Yan, Professor, Medical Research Center, Taizhou Hospital of Zhejiang Provinve, China
13:55-14:20
Title: New Stochastic Models of Carcinogenesis for Human Cancer Involving Multiple Pathways
Dr. Hong Zhou, Assistant Professor, Department of Mathematics and Statistics, Arkansas State University,
USA
14:20-14:45
Title: The Histone Demethylase JMJD1A Promotes Neuroblasotma Cell Metastasis Through Modulating
Gene Transcription
Dr. Tao Liu, Group Leader, Children's Cancer Institute Australia for Medical Research(CCIA), Australia
14:45-15:10
Title: STAT3 is Involved in Esophageal Carcinogenesis through Regulation of Oct-1
Dr. Zhipeng Wang, Associate Professor, Fourth Military Medical University, China
15:10-15:25
Coffee Break
15:25-15:50
Title: MicroRNA-499-5p Promotes Cellular Invasion and Tumor Metastasis in Colorectal Cancer by
Targeting FOXO4
Dr. Haifeng Jin, The Fourth Military Medical University, China
15:50-16:15
Title: Human Papillomavirus Genotyping in Ovarian Cancer Saudis Patients
Dr. Mohamed M. Hafez, Associate Professor of Virology and Immunology, Department of Cancer Biology,
National Cancer Institute, Egypt
Chapter 4: Personalized Medicine and Translational Medicine
Stream 401: Personalized Medicine and Translational Medicine
Time: 13:30-17:05, May 23, 2013 (Thursday) Place: Yu Lin A Hall, 2nd Floor, Hilton Xi'an
Chair
Co-Chair
13:30-13:55
Dr. Christian Ensinger, Professor, Institute of Pathology, Medical University of Innsbruck, Austria
Dr. Lei L Chen, Retired Associate Professor of Medicine, MD Anderson Cancer Center, USA
Title: Exploiting Antitumor Immunity to Overcome Relapse��Rational, Efficacy in Gastrointestinal
Stromal Tumor Model, and Implications in Other Malignancies
Dr. Lei L Chen, Retired Associate Professor of Medicine, MD Anderson Cancer Center, USA
13:55-14:20
Title: Changes in Pathological Investigations from Histopathology to Molecular Evaluations Concerning
Personalized Medicine in Cancer Treatment
Dr. Christian Ensinger, Professor, Institute of Pathology, Medical University of Innsbruck, Austria
14:20-14:45
Title: Biobank and Its Application in Translational Medicine
Dr. Hengjun Gao, Professor and Director, Biobank Brank Branch, China Medical Biotech Association,
National Engineering Research Center, China
14:45-15:10
Title: Advanced High-Content Tissue Cytometry as an Essential Tool in Personalized Medicine
Dr. Rupert C. Ecker, Chief Scientific Officer, Tissue Gnostics GmbH, Austria
15:10-15:25
Coffee Break
15:25-15:50
Title : Patient-derived First Generation TumourXenograft Model: A Promising Tool for Rapid Guidance of
Chemotherapeutic Responsiveness in Patients with Pancreatic Cancer
Dr. Aiqun Xue, Senior Research Fellow, Royal North Shore Hospital, Australia
15:50-16:15
Title: Plasmatic Levels of Angiogenetic and Immunosupressive Factors TGF Beta1, VEGF and Antitumor
Cellular Immunity in Patients with Breast and Colon Cancer
Dr. Eva Zavadova, Clinical Immunologist, Department of Oncology, General Teaching Hospital and 1st
Faculty of Medicine, Charles University, Prague, Czech Republic
16:15-16:40
Title: Phytochemicals and Drug Resistance in Pancreatic Cancer Chemotherapy
Dr. Yan Li, Senior Lecturer, Auckland University of Technology, New Zealand
16:40-17:05
Title: Thioredoxin-Dependent Cancer Prevention and Inflammatory Diseases
Dr. Junji Yodoi, Professor, Kyoto University, Japan
Chapter 5: Medical Research on Solid Tumors
Stream 501: Breast Cancer
Time: 16:15-17:55, May 23, 2013 (Thursday) Place: Yu Lin B Hall, 2nd Floor, Hilton Xi'an
Chair
Dr. Shi Wei, Assistant Professor, University of Alabama at Birmingham, Medical Director,
Immunohistochemistry Laboratory, UAB Hospital, USA
16:15-16:40
Title: What We Know about Primary Metastatic Breast Cancer – Pathological Characteristics and
Outcome over a 10-year Period
Dr. Jana Barinoff, Gynecological Oncologist, Kliniken Essen-Mitte, Germany
16:40-17:05
Title: Breast Cancer with Isolated Bone Metastatic Potential: A Different Animal?
Dr. Shi Wei, Assistant Professor, University of Alabama at Birmingham, Medical Director,
Immunohistochemistry Laboratory, UAB Hospital, USA
17:05-17:30
Title: Incorporation of Cost-effective Agents for the Prevention of Cancer Treatmentinduced Toxicities
Dr. Biswa Mohan Biswal, Professor, School of Medical Sciences, University Science Malaysia, Malaysia
17:30-17:55
Title: Polysaccharide Suppresses Progression of Cancers via Inhibition of Transforming Growth Factor-β1
Receptors (TGFRs)-mediated Signals and Epithelial-to-mesenchymal Transition
Dr. Hsien-Yeh Hsu, Professor, Yang-Ming University, Taiwan
Stream 502: Colorectal Cancer, Colon, Rectal and Anal Cancer Management
Time: 13:30-17:05, May 23, 2013 (Thursday) Place: Yu Huan Hall, 1st Floor, Hilton Xi'an
Chair
13:30-13:55
Dr. Amale Laouar, Assistant Professor, Robert Wood Johnson Medical School-UMDNJ, USA
Title: 2B4 is a Major Marker of Gut Immune Cells Induced and Maintained by the Intestinal Microbial Flora:
Impact of the Intestinal Microbial Flora on Gut Immune Cells
Dr. Amale Laouar, Assistant Professor, Robert Wood Johnson Medical School-UMDNJ, USA
13:55-14:20
Title: New Frontiers in Colorectal Cancer Surgery: The Rise of the Laparoscopist
Mr. Adnan Alam, Consultant Colorectal Surgeon, Addenbrooke's Hospital, UK
14:20-14:45
Title: Effects of Abdominal Surgery on Postoperative Trunk Flexion Strength in Patients with Colorectal
Cancer
Ms. Irena Paiuk, Physical Therapist, The Stanley Steyer School of Health Professions, Department of
Physical Therapy, Tel Aviv University, Israel
14:45-15:10
Title: Surgery of Colorectal Cancer in the Small Town of Komotini
Dr. Christos Sotirios Simoglou, Surgical Clinic, Sismanogleio General Hospital, Greece
15:10-15:25
Coffee Break
15:25-15:50
Title: Perineal Approach for Resection of Carcinoma of Lower Third Rectum with Perineal Continent
Colostomy
Dr. Shantikumar Dhondiram Chivate, Sr.Surgeon, JeevanJyot Hospital Thane, India
15:50-16:15
Title: Tumor Specific Suppressor Bax Δ2 Family in MSI Tumors
Dr. Jialing Xiang, Associate Professor, Illinois Institute of Technology, USA
16:15-16:40
Title: Pathogen-driven Colorectal Cancers: Time for a Treatment Paradigm Change?
Dr. Bauyrzhan Aituov, Junior Researcher, Nazarbayev University, Kazakhstan
16:40-17:05
Title: Discovery of Novel Microtubule Polymerization and Depolymerization Inhibitor with Potent
Antiproliferative and Antitumor Activity
Dr. Lijuan Chen, Professor and Vice Director of State Key Laboratory of Biotherapy, Sichuan University,
China
Stream 503: Head, Neck, Nasopharyngeal, Oral Cavity
Time: 08:30-11:40, May 24, 2013 (Friday) Place: Yu Huan Hall, 1st Floor, Hilton Xi'an
Chair
Co-Chair
Dr. James Kevin Fortson, Chief, ENT Associates of South Atlanta, USA
Dr. Ming-Liang He, Associate Professor, Stanley Ho Center for Emerging Infectious Diseases, The
Chinese University of Hong Kong, The Chinese University of Hong Kong, China
08:30-08:55
Title: Head and Neck Cancer Screening in National and High-risk Populations in Ireland
Dr. Eleanor O’Sullivan, Clinical Lecturer, Chair of Mouth Head & Neck Cancer Awareness Ireland, Cork
University Dental Hospital, Ireland
08:55-09:20
Title: Study of the Lengh of Hospital Stay for Free Flap Reconstruction of Oral and Pharyngeal Cancer in
the Context of the New French Casemix-based Funding and Comparison between Two Periods
Dr. Angelique Girod, Medical Doctor, Institut Curie Comprehensive Cancer Center, France
09:20-09:45
Title: Nutritional Therapy for Patients with Head and Neck Cancer
Dr. Jens Buentzel, Chair, Palliative Care Unit, SuedharzKlinikumNordhausen, Germany
09:45-10:10
Title: Carcinoma Involving the Sphenoid Sinus
Dr. James Kevin Fortson, Chief, ENT Associates of South Atlanta, USA
10:10-10:25
Coffee Break
10:25-10:50
Title: MiR-26a Inhibits Cell Growth and Tumorigenesis of Nasopharyngeal Carcinoma through Repression
of EZH2
Dr. Ming-Liang He, Associate Professor, Stanley Ho Center for Emerging Infectious Diseases, The
Chinese University of Hong Kong, Hong Kong, China
10:50-11:15
Title: The Expression and Prognostic Significance of Hepatoma-derived Growth Factor in Oral Cancer
Dr. Yu-Wei Lin, Attending Physician, Chi Mei Medical Center, Taiwan
11:15-11:40
Title: Rare Tumours: Retropharyngeal and Laryngeal Synovial Cell Sarcomas
Dr. Ronald Y Chin, Consultant Otolaryngologist, Head and Neck Surgeon, Lecturer, Nepean Hospital,
The University of Sydney, Australia
Stream 504: Esophagus and Lung Cancer
Time: 13:30-15:10, May 24, 2013 (Friday) Place: Wan Da Hall, 1st Floor, Hilton Xi'an
Chair
Dr. Giulio Tarro, President, Foundation De Beaumont Bonelli, Sbarro Health Research Organization,
Adjunct Professor, Temple University, USA
13:30-13:55
Title: An Introduction to My Approach Concerning the Fusion of Western and Traditional Chinese
Medicine in Clinical and Basic Research of Cancer
Dr. Chen-Yu Lee, Chief of YuSheng Chinese Medicine Clinic; Honorary Chairman of the ROC Chinese
and Western Medicine Neurology Foundation; Honorary Ph.D. Advisor, LiaoNing University of Traditional
Chinese Medicine, Taiwan
13:55-14:20
Title: Human Corin and Tumor Liberated Protein (TLP) in NSCL Cancer: Homology or Different Isoforms
in the Sequence at the Cell Surface
Dr. Giulio Tarro, President, Foundation De Beaumont Bonelli, Sbarro Health Research Organization,
Adjunct Professor, Temple University, USA
14:20-14:45
Title: The Relation between Lymoh Node Metastasis and Recurrent Sites in Esophageal Carcinoma after
Surgery
Dr. Jiancheng Li, Director, Department of Radiation Oncology, Fujian Provincial Cancer Hospital, China
14:45-15:10
Title: FulvestrantIncreasesGefitinib Sensitivity in Non-Small Cell Lung Cancer Cells by Upregulating
Let-7c Expression
Dr. Hua Shen, Department of Oncology, First Affiliated Hospital of Nanjing Medical University, China
15:10-15:25
Coffee Break
Stream 505: Prostate Cancer
Time: 15:25-17:30, May 24, 2013 (Friday) Place: Wan Da Hall, 1st Floor, Hilton Xi'an
Chair
15:25-15:50
Dr. Patricia Tai, Professor, University Saskatchewan, Allan Blair Cancer Center, Canada
Title: The Management of Prostate Cancer with Very High PSA (Prostatic Specific Antigen)
Dr. Patricia Tai, Professor, University Saskatchewan, Allan Blair Cancer Center, Canada
15:50-16:15
Title: Racial Differences in the Receipt of Definitive Treatment for Clinically Localized Prostate Cancer
Dr. Willie Underwood, Associate Professor, Roswell Park Cancer Institute, USA
16:15-16:40
Title: Contemporary Management of Castration Resistant Prostate Cancer (CRPC)
Dr. Hüseyin Engin, Head of the Department of Internal Medicine and Medical Oncology, BülentEcevit
University Cancer Center, Turkey
16:40-17:05
Title: Prostate Cancer: Long Term Results of Combined Modality Treatment with No Hormonal Use
Dr. Ariel Lederman, Radiosurgery New York, USA
17:05-17:30
Title: Hit by Waves-living with Local Advanced or Localized Prostate Cancer Treated with Endocrine
Therapy or under Active Surveillance
Dr. Kenneth Asplund, Professor, University of Tromsö, Norway
Stream 506: Ureter, Bladder, Genitourinary and Testis Cancers
Time: 13:30-14:20, May 24, 2013 (Friday) Place: Yu Lin B Hall, 2nd Floor, Hilton Xi'an
Chair
13:30-13:55
Dr. Alastair Thomson, Consultant Clinical Oncologist, Royal Cornwall Hospital, UK
Title: Developments in Radiotherapy for the Treatment of Bladder Cancer
Dr. Alastair Thomson, Consultant Clinical Oncologist, Royal Cornwall Hospital, UK
13:55-14:20
Title: Urinary Thrombomodulin is Down Regulated in Schistosomiasis Associated Bladder Cancer
Dr. Ayman Mohamed Metwally, Assistant Professor, College of Applied Medical Science, Misr University
for Science and Technology, Egypt
Stream 507: Kidney Cancer, Renal Cell Cancer and Adrenal Cancers
Time: 14:20-15:35, May 24, 2013 (Friday) Place: Yu Lin B Hall, 2nd Floor, Hilton Xi'an
Chair
Dr. Yili Yang, Staff Scientist, National Cancer Institute at Frederick, USA
14:20-14:45
Title: Renal Cell Carcinoma with Secondary Hemophagocytic Syndrome
Dr. Tze-Wah Kao, Assistant Professor, National Taiwan University Hospital, Taiwan
14:45-15:10
Title: Allergen Removed Rhus Verniciflua Stokes Extract (aRVS) as a Potential Option for Treatment of
Metastatic Renal Cell Carcinoma (mRCC)
Dr. Sookyung Lee, Associate Professor, Kyung Hee University Hospital, Korea
15:10-15:35
Title: Exploring the Mechanisms of Wilms' Tumor Development in Animal Models
Dr. Yili Yang, Staff Scientist, Cancer and Developmental Biology Laboratory, National Institutes of Health,
USA
Stream 508: Brain Cancer
Time: 08:30-10:10, May 25, 2013 (Saturday) Place: Yan An Hall, 2nd Floor, Hilton Xi'an
Chair
08:30-08:55
Dr. Michael Repacholi, Visiting Professor, University of Rome "La Sapienza", Italy
Title: Does Mobile Phone Use Cause Head Cancers?
Dr. Michael Repacholi, Visiting Professor, University of Rome "La Sapienza", Italy
08:55-09:20
Title: Cytoplasmic Expression of HspB11 Correlates with the Clinical Grade of Brain Tumors
Dr. Ferenc Gallyas, Professor, University of Pecs Medical School, Hungary
09:20-09:45
Title: Proliposomes: A Promising Formulation Approach of Liposomes for the Treatment of Brain Tumour
Dr. Abdelbary Elhissi, Head of Drug Delivery Division, Institute of Nanotechnology and Bioengineering,
University of Central Lancashire, UK
09:45-10:10
Title: Isolated Intracranial Rosai-dorfman Disease Mimicking Meningioma in a Child: A Case Report and
Review of the Literature
Dr. Naman Basant Bagdi, Consultant Interventional Radiologist, India
10:10-10:25
Coffee Break
Stream 509: Overian, Cervical, Vulva, Vagina, Uterine Malignancies and Endometrial Cancers
Time: 10:25-12:05, May 25, 2013 (Saturday) Place: Yan An Hall, 2nd Floor, Hilton Xi'an
Chair
10:25-10:50
Dr. Juergen Engel, President and CEO, AEternaZentaris Inc., Canada
Title: A Role for Estrogen Receptor Beta in Endometrial Cancer?
Dr. Philippa TK Saunders, Professor, MRC Centre for Reproductive Health, The University of Edinburgh,
UK
10:50-11:15
Title: AEZS-108 / 125 – A New Targeting Approach for Breast and Gynaecological Cancers
Dr. Juergen Engel, President and CEO, AEternaZentaris Inc., Canada
11:15-11:40
Title: The Use of Hemi-V-Y Fasciocutaneous Advancement Flaps for Reconstruction of the Vulva after
Radical Surgery
Dr. Max A. Clark, Associate Professor, Wright State University School of Medicine, USA
11:40-12:05
Title: The Primary Study Of Molecular Classification Of Human Endometrial Cancer
Dr. JianLiu Wang, Professor and Vice Chairman,Department of Obstetrics and Gynecology,
Peking University People's Hospital, China
Chapter 6: Diagnosis and Prognosis of Cancers
Stream 601: Diagnosis and Prognosis of Cancers
Time: 13:30-17:55, May 23, 2013 (Thursday) Place: Zhao Jun Hall, 1st Floor, Hilton Xi'an
Chair
Co-Chair
Dr. Beiyun Chen, Associate Professor, Department of Pathology and Laboratory, Mayo Clinic, USA
Dr. Simona Gurzu, Associate Professor, Department of Pathology, University of Medicine and Pharmacy
of TarguMures, Romania
13:30-13:55
Title: Depleted Blood Levels of GTA-446 as a Sensitive Biomarker of Colorectal Cancer
Dr. Dayan Goodenowe, President and CEO, Phenomenome Discoveries Inc., Canada
13:55-14:20
Title: Circulating Tumor Cells in Breast Cancer
Dr. Beiyun Chen, Associate Professor, Mayo Clinic, USA
14:20-14:45
Title: CTCs&CSCs: Does These Rare Events Keep All the Necessary Information about the Appearance
of Metastasis and Pleomorphic of the Disease? Evidence and Facts after Multiple Form Analysis
Dr. Ioannis Papasotiriou, Medical Director, R.G.C.C.-Research Genetic Cancer Centre Ltd, Greece
14:45-15:10
Title: Detection of a-Fetoprotein and Glypican-3 mRNAs in the Peripheral Blood of Hepatocellular
Carcinoma Patients by Using Multiple FQ-RT-PCR
Dr. Qingfang He, Associate Chief Technician, Zhejiang Provincial Center for Disease Prevention and
Control, China
15:10-15:25
Coffee Break
15:25-15:50
Title: Diagnosis and Treatment of Multiple Myeloma and AL Amyloidosis with Focus on Improvement of
Renal Lesion
Dr. Kenshi Suzuki, Director of Department of Hematology, Japanese Red Cross Medical Center, Japan
15:50-16:15
Title: Febrile Complications after Endobronchial Ultrasound-guided Transbronchial Needle Aspiration for
Intra-pulmonary Mass Lesions of Lung Cancer
Dr. Kazuyoshi Imaizumi, Professor, Division of Respiratory Medicine and Clinical Allergy, Department of
Internal Medicine, Fujita Health University, Japan
16:15-16:40
Title: Platform Evaluation in Isolation of Circulating Tumor Cells in Lung Cancer Patients
Dr. Dimple Chudasama, Thoracic Research Associate, Royal Brompton & Harefield NHS Trust, UK
16:40-17:05
Title: Histogenesis of Kaposi Sarcoma - A Challenging Issue
Dr. Simona Gurzu, Associate Professor, Department of Pathology, University of Medicine and Pharmacy
of TarguMures, Romania
17:05-17:30
Title: Plasmablastic Lymphoma of Oral Cavity - Microscopic to Molecular Magnitude with Review of Cases
Dr. Neeta Bagul, Professor, Dr. D. Y. Patil Dental College and Hospital, India
17:30-17:55
Title: Tio2 Nanomaterials for Biosensing Applications of Anticancer Drugs and Cancer Cells
Dr. Jingjie Cui, Associate Professor, College of Life Information Science & Instrument Engineering,
Hangzhou Dianzi University, China
Chapter 7: Cancer Nursing and Integrative Medicine
Stream 701: Oncology Nursing
Time: 13:30-16:15, May 23, 2013 (Thursday) Place: Yu Lin B Hall, 2nd Floor, Hilton Xi'an
Chair
Dr. Margaret I Fitch, Head of Oncology Nursing and Director, Odette Cancer Center, Sunnybrook Health
Sciences Centre, Canada
Co-Chair
13:30-13:55
Dr. Tamis C. Besse, University Hospital Nijmegen, The Netherlands
Title: Medical Oncologist Attitudes and Practice in Cancer Pain Management: A National Survey
Dr. Brenda Breuer, Epidemiologist, Department of Pain Medicine & Palliative Care, Beth Israel Medical
Center, USA
13:55-14:20
Title: Self-care Self-efficacy Effects on Patients' Quality of Life
Dr. Elise Lev, Professor, Rutgers University, USA
14:20-14:45
Title: The Dutch National Guideline: Diagnosis and Treatment in Patients with Pain and Cancer
Dr. Tamis C. Besse, Anesthesiologist, FIPP, University Medical Centre Nijmegen, The Netherlands
14:45-15:10
Title: Creating a Survivorship Program
Dr. Margaret I Fitch, Head of Oncology Nursing and Director, Odette Cancer Center, Sunnybrook Health
Sciences Centre, Canada
15:10-15:25
Coffee Break
15:25-15:50
Title: Acute Oncology Service: Improving Patient Care and Outcome
Dr. Charlotte Thomson, Locum Consultant in Medical Oncology, Weston General Hospital, UK
15:50-16:15
Title: The Nutritional Status in Patients Undergoing Pancreatoduodenectomy
Dr. Maria G Serna-Thome, Medical Nutrition Department, National Institute of Cancerología Av San
Fernando, Mexico
Stream 702: Integrative Medicine and Interventional Methods in Oncology
Time: 13:30-17:30, May 25, 2013 (Saturday) Place: Yu Lin B Hall, 2nd Floor, Hilton Xi'an
Chair
Dr. Gerry Bodeker, Professor, Columbia University; Oxford University, UK
Co-Chair
Dr. Yves Jean Bignon, Professor and Director, Department of Oncogenetics, Jean Perrin Center, France
13:30-13:55
Title: Roles of Melatonin Suppression and Circadian Disruption due to Light Pollution in Cancer Causation
Dr. Russel J. Reiter, Professor, University of Texas Health Science Center, USA
13:55-14:20
Title: « PACThe » Programme for Accompagnying Breast Cancer Patients after Completion of
Chemotherapy : Results of a Randomized Trial on 251 Patients
Dr. Yves Jean Bignon, Professor and Director, Jean Perrin Comprehensive Cancer Center, France
14:20-14:45
Title: The Traditional Chinese Medicine to Anticancer
Dr. Tao Chen, Professor, The Medical College of Three Gorges University, China
14:45-15:10
Title: Use of RFA to Control Hepatic Metastases from Neuroendocrine Malignancy
Dr. Florencia Que, Associate Professor of Surgery, Mayo Clinic, USA
15:10-15:25
Coffee Break
15:25-15:50
Title: Integrative Oncology Meets Immunotherapy: New Prospects for Combination Therapy
Dr. Gerry Bodeker, Professor, Columbia University; Oxford University, UK
15:50-16:15
Title: Quercetin Exerts Anti-melanoma Action and Inhibits STAT3 Signaling
Dr. Zhiling Yu, Associate Professor, Director, Research and Development Division, School of Chinese
Medicine, Hong Kong Baptist University, Hong Kong, China
16:15-16:40
Title: Cancer Rehabilitation at the Mayo Clinic
Dr. Kenley D. Schmidt, Assistant Professor, Mayo Clinic, USA
16:40-17:05
Title: Postoperative Critical Care of the Surgical Oncology Patient: Advances and Special Considerations
Dr. Mark Sawyer, Assistant Professor of Surgery, Mayo Clinic, USA
17:05-17:30
Title: Information Wave of P53 Could be Used for the Anti-cancer Therapy
Dr. Won H. Kim, Professor, Department of Biochemistry, Wonju College of Medicine, Yonsei
University, Korea
Chapter 8: Cancer Biomarkers
Stream 801: Genomic, Proteomic and Transcriptomic-based Biomarkers in Cancer
Time: 08:30-12:55, May 24, 2013 (Friday) Place: Yu Lin A Hall, 2nd Floor, Hilton Xi'an
Chair
Co-Chair
08:30-08:55
Dr. Jianhua Luo, Professor, University of Pittsburgh School of Medicine, USA
Dr. Peter Selby, Professor, University of Leeds, UK
Title: Clinical Proteomics in Renal Cancer
Dr. Peter Selby, Professor, University of Leeds, UK
08:55-09:20
Title: Genome Biomarkers of Prostate Cancer
Dr. Jianhua Luo, Professor and Director, University of Pittsburgh School of Medicine, USA
09:20-09:45
Title: Proteins Differentially Expressed in Ovarian Surface Epithelial Cells Carrying a BRCA1 Mutation are
Potential Biomarkers for Ovarian Cancer
Dr. Guoxiong (Bob) Xu, Scientist and Director, Jinshan Hospital, Fudan University, China
09:45-10:10
Title: Determination of a Biomarker for Cervix Cancer Using Proteomics on Cervicovaginal Fluid
Dr. Xaveer Van Ostade, Professor, Laboratory of Proteinscience, Proteomics and Epigenetic Signaling
(PPES), Department of Biomedical Sciences, University of Antwerp, Belgium
10:10-10:25
Coffee Break
10:25-10:50
Title: Secretory miRNA as Novel Cancer Biomarkers
Dr. Jian Zhang, Associate Professor, Department of Biochemistry and Molecular Biology, Fourth Military
Medical University, China
10:50-11:15
Title: Collection, Preserving and Transporting of Blood Biomarker
Dr. Xian Wu, Product Specialist, Becton Dickinson Medical Devices (Shanghai) Co Ltd. , China
11:15-11:40
Title: Apolipoprotein Biomarkers for Pancreatic Cancer
Dr. Aiqun Xue, Senior Research Fellow, Royal North Shore Hospital, Australia
11:40-12:05
Title: The Role and Significance of Endothelial Progenitor Cells During Progression, Metastasis, and
Recurrence of Hepatocellular Carcinoma
Dr. De-cai Yu, Hepatobiliary Surgery, Nanjing University, China
12:05-12:30
Title: PPARγ Mediates the Effects of WIN55,212-2, an Synthetic Cannabinoid, on the Proliferation and
Apoptosis of the BEL-7402 Hepatocarcinoma Cells
Dr. Qing Zhao, Professor, Department of Biochemistry,Guangzhou Medical University, China
12:30-12:55
Title: HLA and Cancer: From Geno-susceptibility to Clinical Use
Dr. Liya Ju, Special Representative for International Collaboration, China Relation of Gustave Roussy,
France
Stream 802: Comprehensive Gustave Roussy Cancer Center: Structural, Clinical and Research Projects
Time: 08:30-10:50, May 25, 2013 (Saturday) Place: Yu Lin A Hall, 2nd Floor, Hilton Xi'an
Chair
Co-Chair
Dr. Alexander Maximiliaan Eggermont, Professor and Director, Institute Gustave Roussy, France
Dr. Liya Ju, Special Representative for International Collaboration, China Relation of Gustave Roussy,
France
08:30-08:55
Title: Institut Gustave Roussy and Ongoing Projects
Dr. Alexander Maximiliaan Eggermont, Professor and Director, Institute Gustave Roussy, France
08:55-09:20
Title: Collaboration in Cancer Field between IGR and Chinese Cancer Hospitals
Dr. Liya Ju, Special Representative for International Collaboration, China Relation of Gustave Roussy,
France
09:20-09:45
Title: NanoOxaza, Pre-activated Oxazaphosphorines Prodrugs Designed for Drug Delivery Strategy with
Wide Anticancer Activity
Dr. Angelo Paci, Head of the Pharmacology and Drug Analysis Department, Institut Gustave Roussy,
France
09:45-10:10
Title: The Relapse Risk after Autologous Transplantation in Patients with Newly Diagnosed Myeloma is
Not Dependant of the Tumor Cell Load among Infused Cells and the Outcome is Not Improved by
CD34+Cell Selection: Long Term Follow-up of an EBMT Phase III Randomized Study
Dr. Jean-Henri Bourhis, Institut Gustave Roussy, France
10:10-10:25
Coffee Break
10:25-10:50
Title: Insights in Retroperitoneal Sarcomas: New Technical Considerations in Surgery from E-Surge, a
Master Class in Sarcoma Surgery, and Presentation of an Ongoing International Trial from
EORTC–STBSG
Dr. Sylvie Bonvalot, Head of Visceral Surgery, Institute Gustave Roussy, France
Stream 803: Cancers Biomarkers
Time: 08:30-11:50, May 25, 2013 (Saturday) Place: Yu Lin B Hall, 2nd Floor, Hilton Xi'an
Chair
Co-Chair
Dr. Erwin Schleicher, Professor, University of Tuebingen, Germany
Dr. Gerson Ludecke, Senior Staff Urologist and Medical-Oncologist, Department of Urology, UKGM
Giessen, University Clinic, Germany
08:30-08:55
Title: Abnormal DNA Content in Cancer Detection and Prognosis
Dr. Bojana Turic, President and CEO, Perceptronix Medical Inc ., Canada
08:55-09:20
Title: Ocurrence and Relevance of Maillard Products in Cancer
Dr. Erwin Schleicher, Professor, Department of Internal Medicinal, Section Clinical Chemistry, University
of Tubingen, Germany
09:20-09:45
Title: Split-course, High-dose Palliative Pelvic Radiotherapy for Locally Progressive Hormone-refractory
Prostate Cancer
Dr. Nirdosh Kumar Gogna, Professor, Princess Alexandra Hospital-Mater Centre, Australia
09:45-10:10
Title: Comparison of Urine Markers (UBC-rapid, NMP22 BladderChek, BTA-stat) in its Specificity
influenced by Blood
Dr. Gerson Ludecke, Senior Staff Urologist and Medical-Oncologist, Department of Urology, UKGM
Giessen, University Clinic, Germany
10:10-10:25
Coffee Break
10:25-10:50
Title: Cerebrospinal Fluid Interleukin-10 is a Potentially Useful Biomarker in Immunocompetent Primary
Central Nervous System Lymphoma (PCNSL)
Dr. Takashi Sasayama, Assistant Professor, Department of Neurosurgery, Kobe University, Japan
10:50-11:15
Title: RP215 and GHR106 Monoclonal Antibodies as Drug Candidates for Cancer Immunotherapy
Dr. Gregory Lee, Professor Emeritus, UBC Center for Reproductive Health, University of British
Columbia, Canada
11:15-11:50
Title: Cancer and Metastatic Lymph Nodes Obtained by Endobronchial Ultrasound-guided Transbronchial
Needle Aspiration of Carotid Body Tumors
Dr. Takashi Anayama, Assistant Professor, Kochi University, Japan
Chapter 9: Innovative Technologies in Cancer Research
Stream 901: Animal Models and Mathematical Models
Time: 08:30-10:35, May 24, 2013 (Friday) Place: Xian Yang Hall, 2nd Floor, Hilton Xi'an
Chair
Dr. Janne Koch, Facility Manager, Department of Experimental Medicine, Faculty of Health sciences,
University of Copenhagen, Denmark
08:30-08:55
Title: The Cellular Cancer Resistance of the SR/CR Mouse
Dr. Janne Koch, Facility Manager, Department of Experimental Medicine, Faculty of Health sciences,
University of Copenhagen, Denmark
08:55-09:20
Title: Quantitative Radiobiological Model for Evaluating Radiotherapy Plans for Prostate Cancer
Treatment
Dr. Pradip Deb, Senior Lecturer, School of Medical Sciences, RMIT University, Australia
09:20-09:45
Title: Effects of Oral Administration of Fucoidan Extracted from Cladosiphonokamuranus on Tumor
Growth and Survival Time in a Tumor-Bearing Mouse Model
Dr. Yoshiharu Okamoto, Professor, Tottori University, Japan
09:45-10:10
Title: Genome-wide Screening of Genes and Genetic Pathways involved in Mouse Pancreatic Cancer
Metastasis Using an Orthotopic Mouse Model
Ms. Fang Cao, Department of Pathology, Institute of Basic Medical Sciences, Chinese Academy of
Medical Sciences & Peking Union Medical College, China
10:10-10:35
Title: Trans-PET® — A Powerful Tool in Cancer Research
Mr. Lu Wan, Product Specialist, Riverine Technology, China
Stream 902: Cancer Stem Cells
Time: 10:35-12:40, May 24, 2013 (Friday) Place: Xian Yang Hall, 2nd Floor, Hilton Xi'an
Chair
Dr. LuZhe Sun, Professor and Dielmann Endowed Chair in Oncology, Department of Cellular & Structural
Biology, University of Texas Health Science Center at San Antonio, USA
Co-Chair
10:35-11:00
Dr. Tao Ye, Professor, Hong Kong Polytechnic University, China
Title: Novel Histone Demethylase LSD1 Inhibitors Selectively Targets Cancer Cells with Pluripotent Stem
Cell Properties
Dr. Tao Ye, Professor, Hong Kong Polytechnic University, China
11:00-11:25
Title: Mammary Stem Cell and Tumorigenesis
Dr. LuZhe Sun, Professor and Dielmann Endowed Chair in Oncology, Department of Cellular & Structural
Biology, University of Texas Health Science Center at San Antonio, USA
11:25-11:50
Title: Cancer Stemness: Activation of Stemness Genes in Lung Cancer
Dr. Cheng-Wen Wu, Distinguished Chair, Professor, National Yang-Ming University, Taiwan
11:50-12:15
Title: Microenvironment of Cancer Stem Cells
Dr. Yan Zhang, Professor, School of Life Sciences, Sun Yat-sen University, China
12:15-12:40
Title: A Small-Molecule Library Targeting AML Stem Cells
Dr. Yue Chen, Professor, College of Pharmacy the State Key Laboratory of Medicinal Chemical Biology,
Nankai University, China
Stream 903: Innovative Technologies in Cancer Research
Time: 08:30-10:35, May 25, 2013 (Saturday) Place: Xian Yang Hall, 2nd Floor, Hilton Xi'an
Chair
Dr. Yufeng Li, Associate Professor, Division of Preventive Medicine, Comprehensive Cancer Center,
University of Alabama at Birmingham, USA
08:30-08:55
Title: ROC Analysis Can Improve the Correlation between Histological Grade and Oncotype-Dx
Recurrence Risk in Breast Cancer
Dr. Yufeng Li, Associate Professor, Division of Preventive Medicine, Comprehensive Cancer Center,
University of Alabama at Birmingham, USA
08:55-09:20
Title: The Expression of Tumor Metastasis Suppressor Gene KAI1 and Matrix Metalloproteinase 2 in
Breast Cancer Tissues
Dr. Tong Zhang, Professor, Department of Oncology, Xinxiang Central Hospital, China
09:20-09:45
Title: Integrative Microarray Strategy for Screening and Evaluation of Compounds Modulating Erbb
Receptor Activity in Cancer Cells
Dr. Vehary Sakanyan, Professor, Nantes University &ProtNeteomix, France
09:45-10:10
Title: Realgar (REA) Nanoparticles: Physico-chemical Properties and Anticancer Effects
Dr. Peter Balaz, Professor, Institute of Geotechnics, Slovak Academy of Sciences, Slovakia
10:10-10:35
Title: Nanotechnology in Liver Cancer
Dr. Manfred George Krukemeyer, Lecturer of Surgery, Department of Radio-Oncology,
Paracelsus-Hospital, Germany
Chapter 10: Progress in Cancer Treatment
Stream 1001: Progress in Cancer Treatment
Time: 08:30-12:30, May 24, 2013 (Friday) Place: Yu Lin B Hall, 2nd Floor, Hilton Xi'an
Chair
Dr. Wenge Liu, Associate Research Professor, Department of Bioengineering, Duke University, USA
08:30-08:55
Title: Radiation Therapy for the Treatment of Prostate Cancer – Use of Various Modalities for Prostate
Boost
Dr. Anil K. Sharma, Clinical Professor, University of California, USA
08:55-09:20
Title: High Dose Rate Brachytherapy Boost for the Treatment of Cancer of the Prostate
Dr. AM Nisar Syed, Professor, University of California, USA
09:20-09:45
Title: Injectable Seeds for Brachytherapy of Solid Tumor Using a Self-assembly Polypeptide
Dr. Wenge Liu, Associate Research Professor, Department of Bioengineering, Duke University, USA
09:45-10:10
Title: Management of Advanced Gastric Cancer in Japan, the Difference between Other Countries
Dr. Yasushi Tsuji, Director, KKR Sapporo Medical Center Tonan Hospital, Japan
10:10-10:25
Coffee Break
10:25-10:50
Title: Optimization of Adeno-associated Virus Vector for Cancer Gene Therapy
Dr. Chengwen Li, Assistant Professor, UNC at Chapel Hill, USA
10:50-11:15
Title: Usefulness of a Double Dose Contrast Enhanced Magnetic Resonance Imaging for a Deliniation of
Gross Tumor Volume in Stereotactic Radiotherapy for Metastatic Brain Tumors
Dr. Takeo Takahashi, Professor, Department of Radiation Oncology, Saitama Medical Center, Saitama
Medical University, Japan
11:15-11:40
Title: Improving Minimally Invasive Treatment of Rectal Cancer Through Robotic Assistance
Dr. E. Ortiz Oshiro, Staff surgeon – Professor, Hospital Clínico San Carlos – Universidad Complutense,
Spain
11:40-12:05
Title: Carbohydrate- A New Target of Immunotherapy for Ovarian Cancer
Dr.Chih-Long Chang, Assistant Professor, Institute of Biomedical Science, Mackay Medical College,
Taiwan
12:05-12:30
Title: Transfacial Approach to Skull Base Tumors
Dr. Nicolas Avalos, Professor, Chilean Air Force Hospital, Chile
Chapter 11: Anticancer Drug Discovery
Stream 1101: New Targets, New Technologies for Anticancer Therapeutics (Part I)
Time: 08:30-12:30, May 24, 2013 (Friday) Place: Zhao Jun Hall, 1st Floor, Hilton Xi'an
Chair
08:30-08:55
Dr. Douglas D. Fang, Senior Director, WuXiApptec (Shanghai) Co., Ltd., China
Title: Targeting Tumor Metabolism by Inhibition of Glyoxalases
Dr. Gerd Birkenmeier, Professor, Medical Faculty, University of Leipzig, Germany
08:55-09:20
Title: Identification of Cancer Stem Cells Provides Novel Tumor Models for Drug Discovery
Dr. Douglas D. Fang, Senior Director, WuXiApptec (Shanghai) Co., Ltd., China
09:20-09:45
Title: The History and Current Status of Global Anticancer Drugs Discovery and Development
Dr. Charles Liu, Senior Vice President, Pharmaron, Inc., China
09:45-10:10
Title: Novel Fluorescent Probes Reveal Subcellular Differences that Could Enhance Cancer-targeting
Specificity and Sensitivity
Dr. Ta-Chau Chang, Professor, Institute of Atomic and Molecular Sciences, Academia Sinica, Taiwan
10:10-10:25
Coffee Break
10:25-10:50
Title: Blocking Hypoxia-inducible Pathways Could Enhance the Efficacy of Therapies in Treating
Hepatocellular Carcinoma
Dr. Xue-Ying Sun, Professor, Harbin Medical University, China
10:50-11:15
Title: KIF14 as an Oncogene: A Target for Novel Therapeutics?
Dr. Timothy W. Corson, Assistant Professor, Indiana University School of Medicine, USA
11:15-11:40
Title: Repression of Human Telomerase Reverse Transcriptase Using Artificial Zinc Finger Transcription
Factors
Dr. Won H. Kim, Professor, Department of Biochemistry, Wonju College of Medicine, Yonsei University,
Korea
11:40-12:05
Title: Targeting HDL/Apolipoprotein A-II Nanoparticle for Theranostic Drug Delivery System for Pancreatic
Cancer
Dr. Sohel Julovi, Postdoctoral Research Associate, Cancer Surgery Group, Kolling Institute of Medical
Research, Department of Surgery, Northern Clinical School, The University of Sydney, Australia
12:05-12:30
Title: The Introduction of HL-085-001: A Novel Potential Anti-Cancer Drug
Dr. Hongqi Tian, College of Biotechnology, Tianjin University of Science and Technology, China
Stream 1102: Cancer Targeting Gene-Viro-Therapy(CTGVT)
Time: 13:30-17:55, May 24, 2013 (Friday) Place: Xian Yang Hall, 2nd Floor, Hilton Xi'an
Chair
Dr. Xin-Yuan Liu, Professor and Director, Institute of Biochemistry and Cell Biology, Shanghai Institutes
for Biological Sciences, Chinese Academy of Sciences and Xin Yuan Institute of Medicine and
Biotechnology, College of Life Science, Zhejiang Sci-Tech University, China
13:30-13:55
Title: The "Cancer Targeting Gene-Viro-Therapy" Strategy
Dr. Xin-Yuan Liu, Professor and Director, Institute of Biochemistry and Cell Biology, Shanghai Institutes
for Biological Sciences, Chinese Academy of Sciences and Xin Yuan Institute of Medicine and
Biotechnology, College of Life Science, Zhejiang Sci-Tech University, China
13:55-14:20
Title: Cancer Target Therapy: From Cell Signaling to Clinical Practice
Dr. Jiong Wu, Richard J. Roberts Institute of Biotechnology in China, China
14:20-14:45
Title: Gene-Viro-Therapy Targeting to Cancer Stem Cells
Dr. Qijun Qian, Professor, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University,
China
14:45-15:10
Title: Targeting Leukemia Cells with Oncolytic Adenoviruses Expressing sCAR-ligands
Dr. Gongchu Li, Associate Professor, Zhejiang Sci-Tech University, China
15:10-15:25
Coffee Break
15:25-15:50
Title: Potent Antitumor Activity of Oncolytic Adenovirus Expressing Beclin-1 Via Induction of Autophagic
Cell Death in Leukemia
Dr. Wenbin Qian, Professor, The First Affiliated Hospital, College of Medicine, Zhejiang University, China
15:50-16:10
Title: Targeting Cancer Therapy Based on Survivin Mutants and Recombinant Oncolytic Vaccinia Virus
Vectors
Dr. Hui Yan, Professor, Zhejiang Academy of Medical Sciences, China
16:10-16:35
Title: Antitumor Effect of an Oncolytic Adenovirus Delivering TSLC1 for Hepatocellular Carcinoma via
Induction of Caspase Apoptotic Pathway and Inhibition of Wnt Signal Pathway
Dr. Yigang Wang, Associate Professor, Xinyuan Institute of Medicine and Biotechnology, College of Life
Science, Key Laboratory of Silkworm Bioreactor and Biological Medicine of Zhejiang province, Zhejiang
Sci-Tech University, China
16:35-17:05
Title: Combined Therapy with Cytokine-induced Killer Cells and Oncolytic Adenovirus Expressing IL-12
Induce Enhanced Antitumor Activity
Dr. Cheng Qian, Professor, Institute of Pathology and Southwest Cancer Center, Southwest Hospital,
Third Military Medical University, China
17:05-17:30
Title: Possible Guideline for Managing Terminal Haemorrhage In Palliative Care Patients with Advanced
Cancer Discharged Home at the End of Their Lives
Dr. Edith Ubogagu, Specialist Registrar and Research Fellow in Palliative Medicine, Royal Marsden
Hospital, UK
17:30-17:55
Title: Sensitivity of Cervical CarcinomaCells to Vesicular Stomatitis Virus- induced Oncolysis: Potential
Role of Human Papilloma Virus Infection
Dr. Jia-Hu Wang, Centre for Cancer Therapeutics, Ottawa Hospital Research Institute, Canada
Stream 1103: New Targets, New Technologies for Anticancer Therapeutics (Part II)
Time: 13:30-15:35, May 24, 2013 (Friday) Place: Zhao Jun Hall, 1st Floor, Hilton Xi'an
Chair
Dr. Xiaoyan Jiang, Senior Scientist, Associate Professor, BC Cancer Research Centre, University of
British Columbia, Canada
13:30-13:55
Title: A Novel Approach to Target Treatment-Naïve Leukemic Stem Cells
Dr. Xiaoyan Jiang, Senior Scientist and Associate Professor, British Colombia Cancer Agency and
University of British Colombia, Canada
13:55-14:20
Title: The HECTD3 E3 Ubiquitin Ligase Suppresses Cisplatin-induced Apoptosis via Stabilizing MALT1
Dr. Ceshi Chen, Professor, Kunming Institute of Zoology, Chinese Academy of Science, China
14:20-14:45
Title: Targeting Sumo-specific Proteases Toward Discovery of New Anticancer Therapeutics
Dr. Huchen Zhou, Professor, Shanghai Jiao Tong University, China
14:45-15:10
Title: Mitochondrial Targeting of Tocopheryl Succinate Enhances its Pro-apoptotic Efficacy: A New
Paradigm of Efficient Anti-cancer Therapy
Dr. Lanfeng Dong, Senior Research Fellow, Apoptosis Research Group, School of Medical Science,
Griffith University, Australia
15:10-15:35
Title: Triptolide Functions as a Potent Angiogenesis Inhibitor
Dr. Ming-Fang He, Associate Professor, NJUT Sino-America Institute of Translational Medicine, China
Stream 1104: Targeting DNA Damage Response, DNA Repair, Mitosis and Apoptosis
Time: 08:30-11:40, May 25, 2013 (Saturday) Place: Han Zhong Hall, 2nd Floor, Hilton Xi'an
Chair
08:30-08:55
Dr. Bernd Kaina, Professor, Department of Toxicology, University Medical Center, Germany
Title: A New AminothiolRadioprotector to Suppress Radiation DNA Damage and Cancer
Dr. William Fahl, Professor, University of Wisconsin-Madison; Founder, Chairman and Chief Scientific
Officer, ProCertusBioPharm, Inc., USA
08:55-09:20
Title: Reversal of Apoptosis in Cancer and Normal Cells – Possible Linked with Cancer Recurrent and
Tumor Formation
Dr. Ming Chiu Fung, Professor, School of Life Sciences, The Chinese University of Hong Kong, Hong
Kong, China
09:20-09:45
Title: Verticillin A Overcomes Apoptosis Resistance in Human Colon Carcinoma through DNA
Methylation-Depend
Dr. Fei-Yan Liu, Professor, Zhejiang University, China
09:45-10:10
Title: The O6-Alkylguanine Response in the Therapy of Glioma and Melanoma
Dr. Bernd Kaina, Professor, Department of Toxicology, University Medical Center, Germany
10:10-10:25
Coffee Break
10:25-10:50
Title: Targeting Aurora Kinase in Cancer Therapy
Dr. Quentin Qiang Liu, Professor and Director, Institute of Cancer Stem Cell, Dalian Medical University,
China
10:50-11:15
Title: Role of PARP Inhibitors in the Regulation of Cell Death and Inflammatory Processes
Dr. Bela Melegh, Professor, University of Pecs Medical School, Hungary
11:15-11:40
Title: Investigation of the Mechanisms of Synergy between Aurora Kinase A Inhibitor and Low
Concentration Paclitaxel
Dr. Yao Lin, Research Associate, Cancer Research UK Cambridge Institute, University of Cambridge, UK
Stream 1105: Targeting Signaling Pathways and Signal Transduction
Time: 13:30-15:10, May 25, 2013 (Saturday) Place: Yu Lin A Hall, 2nd Floor, Hilton Xi'an
Chair
Co-chair
13:30-13:55
Dr. Yi Charlie Chen, Professor, Natural Science Division, Alderson-Broaddus College, USA
Dr. Shudong Zhu, Professor, Central South University, China
Title: How to Select Indications for Targeted Therapies such as a MEK Inhibitor Based on Biological
Understanding, Preclinical Models and Early Clinical Activity Signals for Rational Choices of Target
Indications
Dr. Bruno Osterwalder, Senior Vice President, Senior Strategic Advisor Oncology, Merck Serono
Darmstadt, Switzerland
13:55-14:20
Title: Targeting HIF Signaling to Inhibit Tumor Angiogenesis by a Novel Bioactive Compound
Chaetoglobosin K
Dr. Yi Charlie Chen, Professor, Natural Science Division, Alderson-Broaddus College, USA
14:20-14:45
Title: PI3K Iinhibition Potentiates Bcl-2 Dependent Apoptosis in Renal Carcinoma Cells
Dr. Shudong Zhu, Professor, Central South University, China
14:45-15:10
Title: Differential Protein Expression In Human Chronic MyelogenousLeukaemia Cell Line (K562)
Following Exposure to 2-Methoxy-1,4-Naphthoquinone Isolated from Impatiens Balsamina Linn
Dr. Anthony Ho Siong Hock, Senior Lecturer, School of Biosciences, Taylor’s University, UniversitiTunku
Abdul Rahman, Malaysia
15:10-15:25
Coffee Break
Stream 1106: Drug Design and Lead Optimization
Time: 15:25-17:30, May 25, 2013 (Saturday) Place: Yu Lin A Hall, 2nd Floor, Hilton Xi'an
Chair
Dr. Jian-Hui Wu, Associate Professor, Departments of Oncology and Medicine, McGill University, Segal
Cancer Centre-Lady Davis Institute, Sir Mortimer B.D.-Jewish General Hospital, Canada
15:25-15:50
Title: Development of Anticancer Agents Targeting Tumor-specific Mutant Proteins
Dr. Jian-Hui Wu, Associate Professor, Departments of Oncology and Medicine, McGill University, Segal
Cancer Centre-Lady Davis Institute, Sir Mortimer B.D.-Jewish General Hospital, Canada
15:50-16:10
Title: Design and Synthesis of Indolin-2-one Derivatives as Multi-Kinase Inhibitors
Dr. Ji-Wang Chern, Professor, School of Pharmacy, National Taiwan University, Taiwan
16:15-16:40
Title: Development of Novel Anti-angiogenic Agents as HIF-1a (HSP90) Inhibitor
Dr. Young-Ger Suh, Professor, College of Pharmacy, Seoul National University, Korea
16:40-17:05
Title: The Quest for Antimetastatic Agents: From Natural Chalcones to Anti-invasive Lead Candidates
Dr. Bart I. Roman, Postdoctoral Researcher, Department of Sustainable Organic Chemistry and
Technology, Ghent University, Belgium
17:05-17:30
Title: Curcuminoids as Inhibitors of Thioredoxin Reductase: A Receptor based Pharmacophore and QSAR
Study
Dr. Durg Vijay Singh, Assistant Professor, Central University of Bihar Patna, India
Chapter 12: Basic Sciences of Oncology
Stream 1201: Tumor System Biology
Time: 08:30-10:10, May 24, 2013 (Friday) Place: Yan An Hall, 2nd Floor, Hilton Xi'an
Chair
Co-Chair
08:30-08:55
Dr. Johannes Haybaeck, Professor, Medical University of Graz, Austria
Dr. Monique Cadrin, Professor, University of Quebec at Trois-Rivieres, Canada
Title: The Thigh Junction Protein Claudin1 Plays a Critical Role in Invasiveness Potential of ShRNA K8/18
Knockdown Epithelial Cancer Cells
Dr. Monique Cadrin, Professor, University of Quebec at Trois-Rivieres, Canada
08:55-09:20
Title: New Concepts on the Understanding of Endometrial Stromal Sarcoma
Dr. Johannes Haybaeck, Professor, Medical University of Graz, Austria
09:20-09:45
Title: Constraints of the Cancer Genome Architecture on Somatic Cancer Evolution - A New Systems
Biology Approach of Cancer Progression
Dr. Albert Rubben, Professor, Department of Dermatology, University Hospital RWTH Aachen, Germany
09:45-10:10
Title: The Novel Human Endogenous Retrovirus-related Gene, psitpte22-HERV, is Silenced by DNA
Methylation in Cancers
Dr. Qiaoyi Liang, Post-doctoral Fellow, Department of Medicine and Therapeutics, The Chinese
University of Hong Kong, CUHK Shenzhen Research Institute, Hong Kong,China
10:10-10:25
Coffee Break
Stream 1202: Cancers Regulations and Tumor Immunology
Time: 10:25-12:30, May 24, 2013 (Friday) Place: Yan An Hall, 2nd Floor, Hilton Xi'an
Chair
Dr. Danny N. Dhanasekaran, Professor, Samuel Noble Foundation Endowed Chair in Cancer Research,
Deputy Director, Peggy and Charles Stephenson Cancer Center, University of Oklahoma, USA
Co-Chair
10:25-10:50
Dr. Yanhua Chen, Associate Professor, East Carolina University, USA
Title: Oncogenic Signaling by LPA in Ovarian Cancer Growth and Progression
Dr. Danny N. Dhanasekaran, Professor, Samuel Noble Foundation Endowed Chair in Cancer Research,
Deputy Director, Peggy and Charles Stephenson Cancer Center, University of Oklahoma, USA
10:50-11:15
Title: Cell Metabolism Revealed
Dr. Denise Chen, Asia-Pacific Application Scientist, Seahorse Bioscience, USA
11:15-11:40
Title: Immunotherapy of Skin Cancer
Dr. Stephen B. Tucker, Clinical Professor, University of Texas Health Science Center, USA
11:40-12:05
Title: Inhibition of Human Lung Cancer Cell Migration and Invasion by Claudin-7 through ERK/ MAPK
Signaling Pathway
Dr. Yanhua Chen, Associate Professor, Brody School of Medicine at East Carolina University, USA
12:05-12:30
Title: The Effect of MGN-3 Arabinoxylan on Innate Imunity Cells
Dr. Jan Sedlak, Director, Cancer Research Institute, Slovak Academy of Sciences, Slovakia
Stream 1203: Tumor Microenvironment
Time: 10:25-12:05, May 25, 2013 (Saturday) Place: Shen Mu Hall, 2nd Floor, Hilton Xi'an
Chair
Dr. Raymond Bergan, Professor, Director of Experimental Therapeutics, Robert H. Lurie Cancer Center
of Northwestern University, USA
10:25-10:50
Title: Therapeutically Targeting the Tumor- Microenvironment Interaction
Dr. Raymond Bergan, Professor, Director of Experimental Therapeutics, Robert H. Lurie Cancer Center
of Northwestern University, USA
10:50-11:15
Title: The Role and Contribution of the Endothelium to Formation of the Premetastatic Niche and to Organ
Specific Metastasis
Dr. Yaw-Chyn Lim, Assistant Professor, National University of Singapore, Singapore
11:15-11:40
Title: Molecular Mechanisms Regulating Expression and Function of Cancer-associated Carbonic
Anhydrase IX
Dr. Jaromir Pastorek, President, Institute of Virology, Slovak Academy of Sciences, Slovakia
11:40-12:05
Title: DACH1 Blocks Prostate Cancer Cell Growth and Interleukin-6 Signaling
Dr. Kongming Wu, Associate Professor, Thomas Jefferson University, USA
Chapter 13: Medical Research on Hematology & Oncology and Endocrine System Tumors
Stream 1301: Medical Research on Hematology & Oncology and Endocrine System Tumors
Time: 13:30-17:05, May 24, 2013 (Friday) Place: Yu Lin A Hall, 2nd Floor, Hilton Xi'an
Chair
Dr. Rajesh C Shrotriya, CEO, Chairman of the Board & President, Spectrum Pharmaceuticals, USA
13:30-13:55
Title: Pralatrexate, a Next Generation Anti-folate, and its Use in the Treatment of Peripheral T-cell
Lymphoma and other Potential Indications
Dr. Rajesh C Shrotriya, CEO, Chairman of the Board & President, Spectrum Pharmaceuticals, USA
13:55-14:20
Title: Clinical Achievements of the EORTC Lymphoma Group and Aspects of Future Group Strategy
Dr. Paul Meijnders, Radiation Oncologist and Associate Professor, University of Antwerp, Belgium
14:20-14:45
Title: Hypofractionated Radiotherapy for Glioblastoma: Strategy for Poor-risk Patients or Hope for the
Future?
Dr. Mohan Hingorani, Consultant Clinical Oncologist, Castle Hill Hospital, UK
14:45-15:10
Title: Long-term Survival of GlioblastomaMultiforme Patients Treated with Tumor-treating Fields
Dr. Aaron M. Rulseh, Radiologist, Na Homolce Hospital, Czech Republic
15:10-15:25
Coffee Break
15:25-15:50
Title: Prognostic Value of Cytomegalovirus in Patients with Glioblastoma and Clinical Implications
Dr. Giuseppe Stragliotto, Director of Medical Neurooncology Unit, Karolinska University Hospital,
Sweden
15:50-16:15
Title: A Comprehensive Study of TP53 Mutations in Chronic Lymphocytic Leukemia: Analysis of 1,287
Diagnostic and 1,148 Follow-up CLL Samples
Dr. Sona Pekova, Head of Laboratory for Molecular Diagnostics, Chambon Inc., Czech Republic
16:15-16:40
Title: Microenvironment and Drug Response in Acute Lymphoblastic Leukemia
Dr. Constantinos Demonacos, Lecturer and Principal Investigator, The University of Manchester, UK
16:40-17:05
Title: A Case of Synchronous Lung Adenocarcinoma and Extranodal Marginal Zone B-Cell Lymphoma of
Mucosa-associated Lymphoid Tissue (MALT) Type
Dr. Chi Young Jung, Associate Professor, School of Medicine, Keimyung University, South Korea